News
05-10-2013, 01:32 AM
A seven-year quest to understand how breast cancer cells resist treatment with the targeted therapy lapatinib has revealed a previously unknown molecular network that regulates cell death. The discovery provides new avenues to overcome drug resistance, according to researchers at Duke Cancer Institute...
More... (http://www.medicalnewstoday.com/releases/260266.php)
More... (http://www.medicalnewstoday.com/releases/260266.php)